Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03433339 · ClinicalTrials.gov registry record · Phase 1
Spinal Cord Stimulation for the Treatment of Major Depressive Disorder
A Phase 1 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT03433339 is a Phase 1 study that has completed, run by University of Cincinnati. The registered enrollment target is 20 participants.
The verdict
NCT03433339, a Phase 1 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot clinical trial will evaluate the efficacy and safety of transcutaneous direct current stimulation (tsDCS) in major depressive disorder.
Interventions
- DEVICE Active transcutaneous spinal direct current stimulation
- DEVICE Sham transcutaneous spinal direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-08-29 |
| Est. Completion | 2022-09-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03433339
The ClinicalTrials.gov registry entry for NCT03433339 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active transcutaneous spinal direct current stimulation is the first listed.
NCT03433339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03433339 about?
NCT03433339 is a clinical study titled "Spinal Cord Stimulation for the Treatment of Major Depressive Disorder". This pilot clinical trial will evaluate the efficacy and safety of transcutaneous direct current stimulation (tsDCS) in major depressive disorder.
What is the current status of trial NCT03433339?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2018-08-29. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT03433339?
The interventions under investigation include: Active transcutaneous spinal direct current stimulation (DEVICE), Sham transcutaneous spinal direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT03433339?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.